No Ryan the failure of the vaccine project was the reason for AVRs financial problems , as a matter of fact it almost lead to the demise of Admedus . Had the ADAPT project not been in development at the same time Admedus would have been liquidated no doubt . Further more had the money wasted on the vaccine project been pumped into ADAPT in those days where would Anteris be now ? Some investors seem to have short memories when it comes to the history of this company . There was a lot of hype about Admedus back in the vaccine days and many investors where swayed to pump money into it due to the success of Gardisil and the fact Mr Fraser was heading up the project . GLTATH
AVR Price at posting:
$21.82 Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)